In the last trading session, 14.51 million CVS Health Corp (NYSE:CVS) shares changed hands as the company’s beta touched 0.53. With the company’s per share price at $56.85 changed hands at -$1.32 or -2.27% during last session, the market valuation stood at $71.52B. CVS’s last price was a discount, traded about -46.44% off its 52-week high of $83.25. The share price had its 52-week low at $52.77, which suggests the last value was 7.18% up since then. When we look at CVS Health Corp’s average trading volume, we note the 10-day average is 15.17 million shares, with the 3-month average coming to 10.30 million.

Analysts gave the CVS Health Corp (CVS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.93. If we narrow down to specifics, the data shows that 0 out of 20 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 6 recommended CVS as a Hold, 14 felt it is a Buy and 0 rated the stock as Underweight. CVS Health Corp’s EPS for the current quarter is expected to be 1.64.

CVS Health Corp (NYSE:CVS) trade information

Instantly CVS was in red as seen at the end of in last trading. With action -12.54%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -28.00%, with the 5-day performance at -12.54% in the red. However, in the 30-day time frame, CVS Health Corp (NYSE:CVS) is -1.25% down. Looking at the short shares, we see there were 19.75 million shares sold at short interest cover period of 2.27 days.

The consensus price target for the stock as assigned by Wall Street analysts is 112, meaning bulls need an upside of 49.24% from its current market value. According to analyst projections, CVS’s forecast low is 63 with 127 as the target high. To hit the forecast high, the stock’s price needs a -123.39% plunge from its current level, while the stock would need to soar -10.82% for it to hit the projected low.

CVS Health Corp (CVS) estimates and forecasts

Data shows that the CVS Health Corp share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -17.01% over the past 6 months, a -25.63% in annual growth rate that is considerably higher than the industry average of -36.80%. Year-over-year growth is forecast to reach 3.20% up from the last financial year.

Consensus estimates given by 17 financial analysts project the company’s revenue in the current quarter to hit an average of 92.75B. 17 analysts are of the opinion that CVS Health Corp’s revenue for the current quarter will be 96.86B. The estimates for the next quarter sales put growth at 3.30%.

The 2024 estimates are for CVS Health Corp earnings to decrease by -25.82%, but the outlook for the next 5-year period is at 3.73% per year.

CVS Dividends

CVS Health Corp is expected to release its next quarterly earnings report in November. The 4.68% annual yield figure for the share gives it an annual dividend of 2.66. It is important to note, however, that the 4.68% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 2.93 per year.

CVS Health Corp (NYSE:CVS)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.12% of CVS Health Corp shares while 83.05% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 83.14%. There are 83.05% institutions holding the CVS Health Corp stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 9.2341% of the shares, roughly 116.35 million CVS shares worth $6.87 billion.

BLACKROCK INC. holds the second largest percentage of outstanding shares, with 7.9485% or 100.15 million shares worth $5.91 billion as of 2024-06-30.